-
公开(公告)号：US20110172263A1
公开(公告)日：2011-07-14
申请号：US13120074
申请日：2009-09-17
IPC分类号： A61K31/437 , C07D221/06 , A61P11/00 , A61P29/00 , A61P19/00 , A61P7/00 , A61P3/10 , A61P37/00
CPC分类号： C07D471/04
摘要： Compound of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
摘要翻译： 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。
-
公开(公告)号：US08546422B2
公开(公告)日：2013-10-01
申请号：US13120067
申请日：2009-09-17
IPC分类号： C07D491/00 , C07D498/00 , C07D513/00 , C07D515/00 , C07D471/00
CPC分类号： C07D471/14
摘要： Compounds of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
摘要翻译： 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。
-
公开(公告)号：US08637671B2
公开(公告)日：2014-01-28
申请号：US13120074
申请日：2009-09-17
IPC分类号： C07D471/04 , A61K31/437
CPC分类号： C07D471/04
摘要： Compound of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
摘要翻译： 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。
-
公开(公告)号：US20110178115A1
公开(公告)日：2011-07-21
申请号：US13120067
申请日：2009-09-17
IPC分类号： C07D471/04 , A61K31/4353
CPC分类号： C07D471/14
摘要： Compounds of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
摘要翻译： 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。
-
-
-
搜索结果
4 条记录 (耗时 0.011 秒)
